AzTrials
AzTrials

Autistic College Students With Anxiety, Depression, StressNCT07682753

MH-POWER for College Students on the Spectrum

A study testing The MH-POWER program in people with Autistic College Students With Anxiety, Depression, Stress, run by University of Texas Rio Grande Valley at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this project is to determine the feasibility and preliminary efficacy of a mental health skill-building and empowerment program (MH-POWER) for college students on the autism spectrum facing stress, anxiety, and depression. Read more about this study

Who is it for?
Ages 18 to 30 years
What is being tested?
The MH-POWER program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
1 Jul 2026to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • College students at The University of Texas Rio Grande Valley
  • age 18-30 years
  • self-reported autism diagnosis confirmed via Social Responsiveness Scale-2nd Edition, the gold standard to assess impairment in adults on the autism spectrum
  • elevated stress, anxiety (worry, feeling overwhelmed), or depression (feeling down), confirmed using highly reliable and validated screening tools; Patient Health Questionnaire-9, General Anxiety Disorder-7, Kessler Psychological Distress Scale-10
  • not currently receiving intensive psychological treatment or psychiatric medication adjustments
  • must be able to speak and read English
  • willing to participate in an 8-week intervention study

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wen-Pin Chang, PhD contact

9566656405

wenpin.chang@utrgv.edu

United States1 site, 1 recruiting
  • Department of Occupational Therapy, ESWOT Building, University of Texas Rio Grande Valley

    Edinburg, Texas, 78539

    Wen-Pin Chang, 9566654605, wenpin.chang@utrgv.edu

    Recruiting

Other trials in United States

About this study

Official title: Empowering Autistic College Students: Mental Health Skill Building at a Hispanic-Serving Institution

The purpose of this project is to determine the feasibility and preliminary efficacy of a mental health skill-building and empowerment program (MH-POWER) for college students on the autism spectrum facing stress, anxiety, and depression. The program, grounded in cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and habit formation, will be implemented through weekly sessions and daily practice over 8 weeks. To evaluate the program's preliminary efficacy, we will measure mental health symptoms at baseline, mid-point, post-intervention, and one-month follow-up. Positive outcomes could lead to scalable interventions.

Being tested
The MH-POWER program
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The MH-POWER programBehavioural

    The MH-POWER program is an 8-week, structured, and manualized program to improve mental health skills. The program design consists of weekly 60-minute group sessions (8-12 in each group) and daily structured practice activities to reinforce the skills learned in each session. Based on the Self-Regulation Framework, the MH-POWER program systematically integrates (a) CBT with a specific focus on cognitive restructuring and behavioral activation; (b) ACT with mindfulness, acceptance strategies, and values clarification; and (c) the science of habit formation, which includes action planning, goal setting, prompts, and self-monitoring. The program focuses on developing greater relationships between thoughts, emotions, and behaviors, as well as the ability to cope effectively. The focus areas of development include learning how thoughts create emotions and influence actions, developing a positive mindset, enhancing stress management and coping skills, employing structured problem

Study groups in NCT07682753
Study groupRoleWhat they receive
The MH-POWER programExperimentalNot described
Receives: Behavioral: The MH-POWER program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived Stress Scale (PSS)

    Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress

    Measured: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)

  2. State-Trait Anxiety Inventory (STAI)

    Each subscale yields a score between 20 and 80, with higher scores indicating greater severity of anxiety.

    Measured: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)

  3. Beck Depression Inventory-II (BDI-II)

    Score ranges from 0-63. Higher scores indicate more severe depressive symptoms

    Measured: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)

Secondary outcomes (2)
  1. Self-Reported Habit Index (SRHI)

    Averaged scores of all items range from 1 to 7, a higher score indicates that the behavior functions as a strong, automatic habit

    Measured: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12).

  2. Mental Health Quality of Life Questionnaire (MHQoL)

    Scores range from 0 to 21, with higher scores indicating better quality of life

    Measured: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2026
  2. Study start1 Jul 2026
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07682753
Sponsor's protocol ID
IRB-26-0155
Status last verified
Jul 2026
First submitted
26 Jun 2026
Last updated
3 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing The MH-POWER program in people with Autistic College Students With Anxiety, Depression, Stress, run by University of Texas Rio Grande Valley at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wen-Pin Chang, PhD (9566656405, wenpin.chang@utrgv.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived Stress Scale (PSS) (time frame: It will be administered at baseline (Week 0), mid-intervention (Week 4), post-intervention (Week 8), and follow-up (Week 12)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in